What is parasympathetic tone, how is it assessed, and how can it be increased or decreased clinically?

Parasympathetic Tone: Definition, Assessment, and Clinical Modulation

Definition

Parasympathetic tone refers to the continuous baseline activity of the parasympathetic nervous system on target organs, particularly the heart, where it exerts a restraining influence that slows heart rate and increases heart rate variability. 1

Under resting conditions, parasympathetic activity is the dominant influence on the sinus node, creating physiologic variation in heart rate that can be measured and quantified. 1 The parasympathetic system affects the overall variability of heart rate, influencing the total power of heart rate variability measurements. 1

Assessment Methods

Heart Rate Variability (HRV) - Primary Assessment Tool

HRV represents the most sensitive and specific method currently available to evaluate parasympathetic tone in clinical research. 1

Time Domain Measures

• Root-mean square of successive R-R interval differences (rMSSD): Directly reflects parasympathetic activity 1
• pNN50: Number of instances per hour where consecutive R-R intervals differ by >50 ms over 24 hours 1
• Standard deviation of 5-minute average R-R intervals (SDANN) 1
• All time domain indices essentially explore parasympathetic activity 1

Frequency Domain Measures

• High-frequency power (HF): Reflects respiratory sinus arrhythmia at approximately 0.25 Hz (12-18 breaths/min), traditionally attributed to parasympathetic activity 1
• Total power: Parasympathetic activity influences the overall variability and total power of the spectrum 1
• Measurement requires controlled or monitored breathing to avoid respiratory artifacts that can confound interpretation 1

Cardiac Vagal Tone - Novel Validated Index

Cardiac vagal tone is a cardiometrically derived index measured using standard three-lead ECG connected via Bluetooth to a smartphone application, requiring only a 5-minute resting recording. 2 This method shows strong positive correlation with established time domain (r=0.8) and frequency domain markers (r=0.75) of heart rate variability. 2

Additional Research Methods

For comprehensive autonomic assessment in research settings, the following are recommended: 1

• Baroreflex sensitivity (BRS)
• Muscle sympathetic nerve activity (MSNA)
• Plasma catecholamines
• Heart sympathetic imaging

Clinical Factors That Decrease Parasympathetic Tone

Pathological Conditions

• Diabetes mellitus with cardiovascular autonomic neuropathy: Progressive loss of parasympathetic function correlates with disease duration 2
• Aging: Negative correlation between cardiac vagal tone and age (r=-0.32) 2
• Sleep deprivation: 36 hours of total sleep deprivation significantly decreases parasympathetic cardiovascular modulation, particularly in seated position 3
• Orthostatic stress: Failure to withdraw parasympathetic tone during upright tilt (as assessed by RMSSD) predicts vasodepressor syncope with 100% specificity 4

Pharmacological Agents

Multiple drugs adversely affect autonomic tone by reducing HRV, including psychotropic drugs, diuretics, and α-adrenoreceptor antagonists. 1

Clinical Strategies to Increase Parasympathetic Tone

Lifestyle Modifications

• Weight loss in obese patients: Accompanied by improvement in cardiovascular autonomic function 1
• Aerobic training: Small interventional studies demonstrate beneficial effects on cardiovascular autonomic indices, with mild physical exercise potentially effective in patients with less severe autonomic dysfunction 1
• Physical activity engagement: In the Diabetes Prevention Program, autonomic function indices improved in subjects with pre-diabetes randomized to lifestyle modification aimed at weight reduction and physical activity 1

Pharmacological Interventions

The following medications have demonstrated increased HRV in diabetic patients: 1

• Cardioselective β-blockers without intrinsic sympathomimetic activity (metoprolol, nebivolol, bisoprolol) - can also treat resting tachycardia associated with autonomic dysfunction
• Angiotensin-converting enzyme inhibitors
• Angiotensin II type 1 receptor blockers
• Digoxin
• Verapamil

Antioxidant Therapy

Phase II randomized controlled trials showed favorable effects on HRV indices using α-lipoic acid, vitamin E, and C-peptide, though further studies are needed for confirmation. 1

Intensive Glycemic Control

In the Steno 2 study, intensive multifactorial cardiovascular risk intervention reduced progression or development of cardiovascular autonomic neuropathy among type 2 diabetic patients with microalbuminuria. 1

Alternative Interventions

Acupuncture: Meta-analysis demonstrates that real acupuncture (without electrical stimulation) has superior effect over placebo in increasing parasympathetic tone, as evidenced by significant changes in high-frequency HRV and LF/HF ratio. 5

Important Clinical Caveats

Heart rate variability measurements must be interpreted cautiously because the relationship between parasympathetic stimulation and HRV is not linear. 6 Phenylephrine-induced changes in HRV are inversely correlated with baseline HRV levels, meaning respiratory variation in parasympathetic effect can be either increased or decreased by parasympathetic stimulation depending on initial parasympathetic tone and stimulation intensity. 6

Breathing pattern critically affects measurement validity: Slow breathing-induced low frequencies are very frequent during spontaneous breathing, explaining poor correlation between direct sympathetic activity measures and low-frequency power. 1 Regularizing breathing rate eliminates respiratory artifacts and improves measurement accuracy. 1